Hypoglycemia and diabetes: increased need for awareness
Charles Shaefer1, Debbie Hinnen2, Christopher Sadler3
1a University Physicians Primary , Augusta , GA , U.S. ;
Current Medical Research and Opinion
|March 10, 2016
Summary
Hypoglycemia, or low blood glucose, poses risks for diabetes patients. Effective prevention strategies, including individualized care and education for patients and healthcare providers, are crucial for managing this condition.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Hypoglycemia, characterized by abnormally low plasma glucose, is a significant concern in diabetes treatment.
- It is frequently associated with both type 1 and type 2 diabetes management, leading to complications and reduced quality of life.
Purpose of the Study:
- To review the impact of hypoglycemia on patients and healthcare practitioners in clinical settings.
- To highlight the importance of recognizing risk factors and high-risk patients for effective prevention and management.
Main Methods:
- Literature review focusing on the clinical impact of hypoglycemia in diabetes.
- Analysis of prevention and management strategies, emphasizing patient and healthcare provider education.
Main Results:
- Hypoglycemia can lead to various complications, diminished quality of life, and increased healthcare costs.
- Preventive measures, including individualized glycemic targets and risk factor assessment, are more effective than treatment alone.
- Patient and healthcare provider education is a key factor in hypoglycemia prevention.
Conclusions:
- Primary healthcare practitioners must prioritize hypoglycemia awareness and management in diabetes care.
- Individualized glycemic goals, consideration of risk factors, and ongoing professional support are essential for prevention.
- While newer diabetes therapies may have lower hypoglycemia risk, long-term safety data are needed, making drug selection critical.
Related Concept Videos
01:15Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
01:22Diabetes Mellitus: Type 2 and Gestational
5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
01:36Carbohydrate Metabolism
14.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.9K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
918
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
918